Table 6.
The effects of extracts on serum hormones and MDA levels in rats
| Item | Groups | --P-- | ||||
|---|---|---|---|---|---|---|
| Control | Sildenafil | Mucuna pruriens | Tribulus terrestris | Ashwagandha | ||
| FSH, mIU/ml | 0.33 ± 0.22 | 0.40 ± 0.37 | 0.31 ± 0.25 | 0.34 ± 0.39 | 0.31 ± 0.24 | >0.05 |
| LH, mIU/ml | 0.22 ± 0.29 | 0.30 ± 0.23 | 0.25 ± 0.17 | 0.24 ± 0.19 | 0.27 ± 0.19 | >0.05 |
| Testosterone, ng/ml | 2.27 ± 0.17c | 4.14 ± 0.71a | 2.57 ± 0.44c | 3.99 ± 0.16ab | 3.58 ± 0.18b | 0.0001 |
| Serum MDA, μmol/L | 0.54 ± 0.05a | 0.56 ± 0.06a | 0.49 ± 0.04b | 0.38 ± 0.02c | 0.44 ± 0.02b | 0.0001 |
| Testis MDA, nmol/g | 1.64 ± 0.09ab | 1.68 ± 0.09a | 1.55 ± 0.06cb | 1.45 ± 0.09d | 1.51 ± 0.07cd | 0.0001 |
FSH follicle-stimulating hormone, LH luteinizing hormone, MDA malonaldeyhde; Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05)